Arca
Skip to content
Tools
Tools

Zidesamtinib

Sold as Jideytro. Every FDA application for this active ingredient.

  • First approved: Jul 22, 2026
  • Applications: 1
  • New uses approved: 0
  • Complete response letters: 0

Applications

NDAs, BLAs and generic ANDAs for this ingredient, oldest first; each opens its full history
ApprovedApplicationSponsorSupplementsMarketing
Jul 22, 2026JideytroNDA 220185 · New molecular entityNuvalent0Marketed

Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Drugs@FDA

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.